Tirzepatide is a synthetic peptide with the CAS number (see your supplier data or standard reference) and a molecular formula of approximately C_42H_54N_8O_10. Our Tirzepatide peptide offers a high purity range of ≥98%, verified by HPLC and mass spectrometry. This level of purity ensures consistency and reliability for preclinical studies and pharmaceutical research, supporting the precise evaluation of its dual receptor activity.
As a GLP-1 and GIP dual agonist, Tirzepatide targets two key incretin receptors to enhance insulin secretion and regulate blood glucose levels. This unique mechanism has shown remarkable potential in managing type 2 diabetes and obesity, with clinical trials demonstrating significant improvements in glycemic control and weight loss. Researchers utilize Tirzepatide in diverse studies exploring metabolic regulation, receptor pharmacology, and peptide therapeutic development.
While Tirzepatide is a dual agonist peptide, Retatrutide represents the next generation by adding a third target: the glucagon receptor (GCGR). This triple agonist activity may provide enhanced metabolic benefits, including greater weight reduction and improved energy expenditure. Although both peptides share GLP-1 and GIP receptor activity, Retatrutide’s broader receptor engagement suggests potential superiority in therapeutic efficacy.
For research institutions and pharmaceutical developers, understanding the nuanced differences between Tirzepatide and Retatrutide is critical. Tirzepatide’s established profile and bulk availability make it ideal for current metabolic and obesity research pipelines. However, incorporating Retatrutide into your studies could unlock next-level insights into triple receptor targeting and metabolic disease treatment.
To explore the full data comparison and detailed analysis of Retatrutide vs Tirzepatide, please visit our dedicated comparison page. Access comprehensive information to guide your research decisions and procurement strategies.
See Full Retatrutide Data →
ShiLai™tirzepatide supplier
Copyright © 2025 ShiLai™tirzepatide supplier - All Rights Reserved.
Powered by ShiLai™tirzepatide supplier